(3.235.41.241)
Users online: 1909    [ij] [ij] [ij] 
Email id
 

Asian Journal of Pharmaceutical Analysis
Year : 2015, Volume : 5, Issue : 4
First page : ( 187) Last page : ( 194)
Print ISSN : 2231-5667. Online ISSN : 2231-5675.
Article DOI : 10.5958/2231-5675.2015.00030.7

Method Development and Validation for Simultaneous Estimation of Telmisartan and Ramipril by UV-Spectrophotometric Method in Pharmaceutical Dosage Form

Vanaja N., Preethi Ch., Dr. Manjunath S.Y., Pal Krishanu

Department of Pharmaceutical Analysis and Quality Assurance, Srikrupa Institute of Pharmaceutical Sciences, Velkatta, Telangana-502277

*Corresponding Author E-mail:

Online published on 29 January, 2016.

Abstract

The present work was aimed at method development and validation for simultaneous estimation of Telmisartan and Ramipril by UV-Spectrophotometric method in pharmaceutical dosage form. In UV method 0.1N NaoH as solvent and λ max of Telmisartan and Ramipril were found to be 232nm and 222nm respectively. Concentration ranges were found to be 4–20μg/mL for both drugs. The R2 values were found to be 0.996 and 0.999 for Telmisartan and Ramipril respectively. The method was validated statistically and by recovery studies. Percentage Assay and Recovery were found to be 95–105% for Telmisartan and Ramipril. LOD and LOQ ranges were found to be 0.177 and 0.539μg/mL and 0.298 and 0.903μg/mL for Telmisartan and Ramipril respectively. This method was validated using ICH guidelines.

Top

Keywords

Telmisartan, Ramipril, UV-Spectrophotometric method, Simultaneous equation, Validation.

Top

  
║ Site map ║ Privacy Policy ║ Copyright ║ Terms & Conditions ║ Page Rank Tool
486,236,086 visitor(s) since 30th May, 2005.
All rights reserved. Site designed and maintained by DIVA ENTERPRISES PVT. LTD..
Note: Please use Internet Explorer (6.0 or above). Some functionalities may not work in other browsers.